Logo

Similar Products

Description

Voriconazole Active Pharmaceutical Ingredient (API) is a critical, high-potency triazole antifungal compound specifically developed for manufacturing medications that address sever...
Voriconazole Active Pharmaceutical Ingredient (API) is a critical, high-potency triazole antifungal compound specifically developed for manufacturing medications that address severe, invasive fungal infections. This essential ingredient targets vulnerable patient populations, including those undergoing cancer treatments, organ transplants, or managing conditions that weaken immune defenses, who face life-threatening risks from fungal pathogens. The API demonstrates proven efficacy against a broad spectrum of dangerous fungi, particularly Aspergillus and Candida species, with consistent molecular stability that ensures reliable performance in finished pharmaceutical formulations. Manufacturers worldwide trust this API for its consistent quality and compliance with international pharmacopeial standards, making it a foundational component in producing life-saving antifungal therapies for global healthcare needs.

This antifungal API serves a vital role across the pharmaceutical manufacturing sector, forming the active core of injectable solutions, oral tablets, and suspension formulations destined for hospital pharmacies and clinical use. It is integral to medications treating invasive aspergillosis, candidemia, and other serious fungal infections prevalent in healthcare settings with vulnerable patients. The industry, including generic drug manufacturers and specialized compounding facilities, depends on Voriconazole API for its documented effectiveness in reducing infection-related mortality and improving treatment outcomes. Its application is particularly crucial in regions with rising numbers of immunocompromised individuals, ensuring healthcare providers maintain consistent access to a potent and reliable antifungal treatment option for critical care.

The business value of Voriconazole API lies in its exceptional reliability, batch-to-batch consistency, and comprehensive regulatory compliance, including adherence to Good Manufacturing Practices (GMP). For buyers, this translates into a trusted raw material that minimizes production risks, ensures end-product efficacy, and supports a strong market reputation. Key differentiators include superior purity profiles, consistent quality documentation with detailed Certificates of Analysis, and a reliable supply chain that supports both large-scale manufacturing and specialized compounding. This reliability enables manufacturers to streamline production, reduce time-to-market for essential antifungal drugs, and build stronger, trust-based partnerships with healthcare providers seeking dependable treatment solutions for their patients.

Key Features:
- High-purity triazole antifungal API with proven broad-spectrum activity against invasive fungal pathogens including Aspergillus and Candida.
- Manufactured under strict GMP guidelines ensuring consistent quality, purity, and regulatory compliance for global pharmaceutical markets.
- Stable molecular structure specifically suitable for various formulations including injectables, tablets, and oral suspensions.
- Comprehensive quality documentation including detailed Certificate of Analysis (CoA) and regulatory support files for seamless production integration.
- Reliable batch-to-batch consistency that ensures predictable and effective performance in finished pharmaceutical products.

Benefits:
- Enables the production of effective antifungal medications that address life-threatening infections in vulnerable patient populations.
- Reduces manufacturing risks through assured consistent quality and comprehensive regulatory compliance documentation.
- Supports formulation flexibility for various delivery methods including injectable, oral, and suspension preparations.
- Enhances clinical treatment outcomes through reliable efficacy against dangerous fungal pathogens.
- Provides pharmaceutical manufacturers with a trusted, high-quality raw material that strengthens product reliability and market competitiveness.

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Voriconazole API is a critical active ingredient formulated into essential antifungal medications, including injectable solutions, tablets, and oral suspensions. It is designed to combat life-threatening systemic fungal infections, with high bioavailability and targeted action making it indispensable for treating immunocompromised patients in hospital and clinical settings where rapid pathogen eradication is paramount for patient survival.

Manufacturers and compounding facilities rely on this API to produce reliable treatments for invasive fungal diseases, meeting stringent pharmacopeial standards for purity and potency. It is specifically engineered for consistent performance in formulations targeting Aspergillus and Candida species, ensuring medications perform reliably in the most demanding healthcare scenarios, from intensive care units to outpatient management of chronic conditions.
- Production of injectable antifungal drugs for hospital treatment of invasive aspergillosis in patients undergoing chemotherapy or stem cell transplants.
- Formulation of oral tablets for managing systemic candidiasis in critical care and ICU settings to improve patient outcomes and reduce mortality.
- Manufacturing preventive and therapeutic medications for organ transplant recipients to combat opportunistic fungal infections during immunosuppression.
- Compounding tailored antifungal therapies in clinical pharmacy settings for patients with specific dosage requirements or delivery challenges.
- Development of reliable generic antifungal medications that provide effective, accessible treatment alternatives within diverse global healthcare systems.

Trade Details

Available StockIn stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Cash on Delivery (COD, if applicable)

Company Profile

Yaksh Pharma
Yaksh Pharma, Maharashtra
Verified
IndiaMaharashtra, India
ManufacturerTrading CompanyImporter / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Pharmaceutical Voriconazole API Antifungal Active Ingredient

Pharmaceutical Voriconazole API is a high-potency triazole antifungal active ingredient for manufacturing injectable and oral medications to treat severe invasive fungal infections like aspergillosis and candidiasis.

Min. Order Quantity: 1 units

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Yaksh Pharma
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier

Related Products